People: Eli Lilly and Co (LLY.N)

LLY.N on New York Stock Exchange

65.80USD
16 Sep 2014
Price Change (% chg)

$0.61 (+0.94%)
Prev Close
$65.19
Open
$65.27
Day's High
$65.91
Day's Low
$64.94
Volume
630,758
Avg. Vol
1,003,906
52-wk High
$65.91
52-wk Low
$47.53

Search Stocks

Kaelin, William 

Brief Biography

Dr. William G. Kaelin Jr., M.D., is Independent Director of Eli Lilly and Co. He is Professor, Department of Medicine and Associate Director, Basic Science; Dana-Farber/Harvard Cancer Center Dr. Kaelin, who is currently serving under interim election, joined the board in June 2012 and was referred to the directors and corporate governance committee by an incumbent independent director. Dr. Kaelin is a professor in the Department of Medicine at the Dana-Farber Cancer Institute and at the Brigham and Women's Hospital, Harvard Medical School, where he began his career as an independent investigator in 1992. He currently serves as associate director, Basic Science, for the Dana-Farber/Harvard Cancer Center. Dr. Kaelin is a prominent member of the medical research community and has received broad recognition for his work in oncology research, including the Canada Gairdner International Award and the Lefoulon-Delalande Prize from the Institute of France. Dr. Kaelin is a member of the Institute of Medicine, the National Academy of Sciences, and the Association of American Physicians.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

John Lechleiter

11,217,000

Derica Rice

5,176,820

Maria Crowe

--

Jan Lundberg

4,774,540

Melissa Barnes

--

Michael Harrington

3,174,220
As Of 30 Dec 2013
Search Stocks